PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Cannabis » Pennsylvania’s Pot Company, Agrimed, Slapped With Cease-And-Desist

Pennsylvania’s Pot Company, Agrimed, Slapped With Cease-And-Desist

by PublicWire
July 31, 2019
in Cannabis
Reading Time: 2 mins read
0

Regulators in Pennsylvania revoked one of the state’s medical cannabis cultivators permit for allegedly violating the production and security regulations.

Roughly a month after a surprise state inspection, the regulators found numbers or violations that raised concerns against Agrimed industries that some plants may have been sold to the black market, according to The Philadelphia Inquirer. Given 30 days to appeal the state’s decision, reportedly entered into a management service agreement with Arizona-based Harvest.

A spokesperson from Harvest did not return requests for comments.

According to the cease-and-desist letter issues in early July, Agrimed, which began operating in February 2018, was growing Cannabis plants. However, its processing equipment was not operational, making the company unable to ship MMJ products to dispensaries. Moreover, the company wasn’t able to produce records establishing what happened to marijuana it grew. It also couldn’t produce security footage as required because it’s security cameras were often non-functional

Under the order, Agrimed was allowed to continue the cultivation of its strains. However, the company was placed on embargo from removing anything from the plants without a department inspector on hand observing and was not allowed to deactivate its security equipment.

The company will suffer due to the cease-and-desist order but will eventually be able to recover in a short period, analysts said. Requirements should be met when they are producing the so-called medicinal drug.

The company should record their distribution of cannabis and would likely maintain its security features active on the whole span of the operation. Nonetheless, this will most likely cause the company to return to its original state and with better functioning facilities.

Since the company was one of the 12 companies that was granted the permit to grow the said medicinal drug. They can bounce back and recover their lost permits and licenses with the proper procedure.

Previous Post

New York’s Pot Decriminalization Not Enough, Says Activists

Next Post

FDA Warns Curaleaf For Illegally Selling Unapproved CBD Products

PublicWire

At PublicWire, we know the vast majority of all investors conduct their due diligence and get their news online in a variety of ways including email, social media, financial websites, text messages, RSS feeds and audio/video podcasts. PublicWire’s financial communications program is uniquely positioned to reach these investors throughout the U.S. and Canada as well as on a global scale.

Related Posts

Photo by GRAS GRÜN on Unsplash
Cannabis

Zenabis returned $1.9 million worth of pot to Sundial over bad quality and visible molds

August 22, 2019
0
Photo by Rick Proctor on Unsplash
Cannabis

Tilray to start exporting medicinal pot to Germany

August 21, 2019
0
Photo by Esteban Lopez on Unsplash
Cannabis

CannTrust stocks fell another 5% after weed distributor returned millions worth of pot

August 20, 2019
0
Photo by Roberto Valdivia on Unsplash
Cannabis

Cannabis stocks fell as possible recession brews

August 14, 2019
0
Cannabis

Aurora Cannabis hovers trade flat amid strong market

August 13, 2019
0
Photo by Get Budding on Unsplash
Cannabis

Health inspectors flagged CannTrust’s non-compliance again, sending stocks down by 26%

August 12, 2019
0
Next Post
Photo by Kimzy Nanney on Unsplash

FDA Warns Curaleaf For Illegally Selling Unapproved CBD Products

Please login to join discussion

Subscribe To Our Newsletter

Loading
Ad
PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2022 publicwire.com

Navigate Site

  • About
  • Contact Us
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • Videos

© Copyright 2022 publicwire.com

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.